Recent Updates
Recently added Catalysts
EW Positive Sentiment

Edwards Lifesciences to Host Investor Event in Conjunction With TCT

Monday, October 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Edwards Lifesciences has announced an investor event coinciding with the TCT annual scientific symposium in San Diego. Scheduled for November 2, the event will feature a live Q&A session with physicians and the company's management team. A live webcast will also be available for broader access to the discussions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Investor event showcases Edwards Lifesciences' commitment to transparency.
  • Live Q&A session allows direct interaction with management and physicians.
  • Webcast accessibility increases investor engagement.

Full Press Release Details

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced that it will host an investor event in conjunction with the TCT annual scientific symposium in San Diego on Monday, Nov. 2, from 5:00 to 6:00 PM Pacific Time. The meeting will include a live Q&A session with physicians and members of the Edwards management team. A live webcast of the event will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived versio

Frequently Asked Questions

When is the Edwards Lifesciences investor event?

The investor event is scheduled for November 2, from 5:00 to 6:00 PM Pacific Time.

Where will the investor event be held?

The event will take place in San Diego during the TCT annual scientific symposium.

Will there be a Q&A session at the event?

Yes, the meeting will include a live Q&A session with physicians and management.

How can I access the event online?

A live webcast of the event will be available on the Edwards Lifesciences investor relations website.

ShareAdd on Google
Tags: EW Edwards Lifesciences investor event TCT symposium live Q&A San Diego
Last updated: Oct 5, 2026

Biotech snapshot

Cash runway
$4253M liquidity · $0M/mo burn
Low dilution risk